International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study

Introduction: In patients treated with direct oral anti activated factor X (anti-FXa) anticoagulants such as apixaban and rivaroxaban, there are several emergency and non-emergency conditions in which anticoagulation activity should be measured. The validity of the common global clotting tests, prot...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Pharmacol
Egile Nagusiak: Ofek, Fanny, Barchel, Dana, Perets, Nofar, Ziv-Baran, Tomer, Mahajna, Ahmad, Filipovich-Rimon, Talia, Garach-Jehoshua, Osnat, Berlin, Maya, Berkovitch, Matitiahu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2019
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6792346/
https://ncbi.nlm.nih.gov/pubmed/31649541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.01177
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak